Tsai D - Search Results

1

The relative capacity of corneal, heart, kidney and skin cells to stimulate allogeneic lymphocytes.

Malinowski K, Tsai D, Manski W. Malinowski K, et al. Among authors: tsai d. Immunol Commun. 1979;8(3):303-11. doi: 10.3109/08820137909050044. Immunol Commun. 1979. PMID: 437826

2

Temporal regulation of Lsp1 O-GlcNAcylation and phosphorylation during apoptosis of activated B cells.

Wu JL, Wu HY, Tsai DY, Chiang MF, Chen YJ, Gao S, Lin CC, Lin CH, Khoo KH, Chen YJ, Lin KI. Wu JL, et al. Nat Commun. 2016 Aug 24;7:12526. doi: 10.1038/ncomms12526. Nat Commun. 2016. PMID: 27555448 Free PMC article.

3

Transcription factor ABF-1 suppresses plasma cell differentiation but facilitates memory B cell formation.

Chiu YK, Lin IY, Su ST, Wang KH, Yang SY, Tsai DY, Hsieh YT, Lin KI. Chiu YK, et al. J Immunol. 2014 Sep 1;193(5):2207-17. doi: 10.4049/jimmunol.1400411. Epub 2014 Jul 28. J Immunol. 2014. PMID: 25070843

4

Uncovering MicroRNA Regulatory Hubs that Modulate Plasma Cell Differentiation.

Tsai DY, Hung KH, Lin IY, Su ST, Wu SY, Chung CH, Wang TC, Li WH, Shih AC, Lin KI. Tsai DY, et al. Sci Rep. 2015 Dec 11;5:17957. doi: 10.1038/srep17957. Sci Rep. 2015. PMID: 26655851 Free PMC article.

5

Blimp-1 Contributes to the Development and Function of Regulatory B Cells.

Wang YH, Tsai DY, Ko YA, Yang TT, Lin IY, Hung KH, Lin KI. Wang YH, et al. Front Immunol. 2019 Aug 14;10:1909. doi: 10.3389/fimmu.2019.01909. eCollection 2019. Front Immunol. 2019. PMID: 31474988 Free PMC article.

6

Regulatory mechanisms of B cell responses and the implication in B cell-related diseases.

Tsai DY, Hung KH, Chang CW, Lin KI. Tsai DY, et al. J Biomed Sci. 2019 Sep 1;26(1):64. doi: 10.1186/s12929-019-0558-1. J Biomed Sci. 2019. PMID: 31472685 Free PMC article. Review.

7

NK cell receptor and ligand composition influences the clearance of SARS-CoV-2.

Hsieh WC, Lai EY, Liu YT, Wang YF, Tzeng YS, Cui L, Lai YJ, Huang HC, Huang JH, Ni HC, Tsai DY, Liang JJ, Liao CC, Lu YT, Jiang L, Liu MT, Wang JT, Chang SY, Chen CY, Tsai HC, Chang YM, Wernig G, Li CW, Lin KI, Lin YL, Tsai HK, Huang YT, Chen SY. Hsieh WC, et al. J Clin Invest. 2021 Nov 1;131(21):e146408. doi: 10.1172/JCI146408. J Clin Invest. 2021. PMID: 34720095 Free PMC article.

8

Fixed-Duration Pirtobrutinib plus Venetoclax with or without Rituximab in Relapsed/Refractory CLL: Phase 1b BRUIN Trial.

Roeker LE, Woyach JA, Cheah CYY, Coombs CC, Shah NN, Wierda WG, Patel MR, Lamanna N, Tsai DE, Nair BC, Wang C, Zhao X, Liu D, Radtke D, Chapman S, Marella N, McNeely SC, Brown JR. Roeker LE, et al. Among authors: tsai de. Blood. 2024 Jun 11:blood.2024024510. doi: 10.1182/blood.2024024510. Online ahead of print. Blood. 2024. PMID: 38861666

9

Safety of extended pirtobrutinib exposure in relapsed and/or refractory B-cell malignancies.

Roeker LE, Coombs CC, Shah NN, Jurczak W, Woyach JA, Cheah CY, Patel K, Maddocks K, Wang Y, Zinzani PL, Munir T, Koh Y, Thompson MC, Muehlenbein CE, Wang C, Sizelove R, Abhyankar S, Hasanabba S, Tsai DE, Eyre TA, Wang M. Roeker LE, et al. Among authors: tsai de. Acta Haematol. 2024 Jun 1. doi: 10.1159/000539587. Online ahead of print. Acta Haematol. 2024. PMID: 38824917

10

Eagle-Eye Inspired Meta-Device for Phase Imaging.

Zhou J, Tian F, Hu J, Shi ZL, Godinez VG, Tsai DP, Liu Z. Zhou J, et al. Among authors: tsai dp. Adv Mater. 2024 May 30:e2402751. doi: 10.1002/adma.202402751. Online ahead of print. Adv Mater. 2024. PMID: 38816897

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

734 results

Search Page